Sharfstein Is Acting FDA Commissioner As Hamburg Awaits Confirmation
This article was originally published in The Tan Sheet
Executive Summary
Josh Sharfstein will begin his FDA career March 30, serving as acting commissioner while awaiting the confirmation of President Obama's nominee for the spot, Margaret Hamburg